Shield Therapeutics PLC
(LSE:STX)
£
0.02725
0.0005 (1.89%)
Market Cap: 28.39 Mil
Enterprise Value: 37.98 Mil
PE Ratio: 0
PB Ratio: 27.51
GF Score: 0/100 Full Year 2023 Shield Therapeutics PLC Earnings Presentation Transcript
Apr 30, 2024 / 01:30PM GMT
Release Date Price:
£0.0135
Operator
Presentation
Apr 30, 2024 / 01:30PM GMT
=====================
Corporate Participants
=====================
* Gregory P. Madison
Shield Therapeutics plc - CEO & Executive Director
* Santosh Shanbhag
Shield Therapeutics plc - CFO
=====================
Gregory P. Madison
Shield Therapeutics plc - CEO & Executive Director
Good afternoon, and welcome to the Shield Therapeutics plc investor presentation. (Operator Instructions) Before we begin, I'd like to submit the following poll.
I'd now like to hand you over to CEO, Greg Madison. Good afternoon, sir.
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot